Skip to main content
NCBI home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 2003 Nov;62(Suppl 2):ii94–ii96. doi: 10.1136/ard.62.suppl_2.ii94

Rheumatoid arthritis in 2003: where are we now with treatment?

M Weinblatt
PMCID: PMC1766746  PMID: 14532160

Full Text

The Full Text of this article is available as a PDF (87.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bathon J. M., Martin R. W., Fleischmann R. M., Tesser J. R., Schiff M. H., Keystone E. C., Genovese M. C., Wasko M. C., Moreland L. W., Weaver A. L. A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis. N Engl J Med. 2000 Nov 30;343(22):1586–1593. doi: 10.1056/NEJM200011303432201. [DOI] [PubMed] [Google Scholar]
  2. Björnådal Lena, Baecklund Eva, Yin Li, Granath Fredrik, Klareskog Lars, Ekbom Anders. Decreasing mortality in patients with rheumatoid arthritis: results from a large population based cohort in Sweden, 1964-95. J Rheumatol. 2002 May;29(5):906–912. [PubMed] [Google Scholar]
  3. Choi Hyon K., Hernán Miguel A., Seeger John D., Robins James M., Wolfe Frederick. Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study. Lancet. 2002 Apr 6;359(9313):1173–1177. doi: 10.1016/S0140-6736(02)08213-2. [DOI] [PubMed] [Google Scholar]
  4. Furst D. E., Koehnke R., Burmeister L. F., Kohler J., Cargill I. Increasing methotrexate effect with increasing dose in the treatment of resistant rheumatoid arthritis. J Rheumatol. 1989 Mar;16(3):313–320. [PubMed] [Google Scholar]
  5. Gabriel S. E., Crowson C. S., O'Fallon W. M. Mortality in rheumatoid arthritis: have we made an impact in 4 decades? J Rheumatol. 1999 Dec;26(12):2529–2533. [PubMed] [Google Scholar]
  6. Gordon P., West J., Jones H., Gibson T. A 10 year prospective followup of patients with rheumatoid arthritis 1986-96. J Rheumatol. 2001 Nov;28(11):2409–2415. [PubMed] [Google Scholar]
  7. Jeurissen M. E., Boerbooms A. M., van de Putte L. B., Doesburg W. H., Lemmens A. M. Influence of methotrexate and azathioprine on radiologic progression in rheumatoid arthritis. A randomized, double-blind study. Ann Intern Med. 1991 Jun 15;114(12):999–1004. doi: 10.7326/0003-4819-114-12-999. [DOI] [PubMed] [Google Scholar]
  8. Jones G., Halbert J., Crotty M., Shanahan E. M., Batterham M., Ahern M. The effect of treatment on radiological progression in rheumatoid arthritis: a systematic review of randomized placebo-controlled trials. Rheumatology (Oxford) 2003 Jan;42(1):6–13. doi: 10.1093/rheumatology/keg036. [DOI] [PubMed] [Google Scholar]
  9. Krause D., Schleusser B., Herborn G., Rau R. Response to methotrexate treatment is associated with reduced mortality in patients with severe rheumatoid arthritis. Arthritis Rheum. 2000 Jan;43(1):14–21. doi: 10.1002/1529-0131(200001)43:1<14::AID-ANR3>3.0.CO;2-7. [DOI] [PubMed] [Google Scholar]
  10. Möttönen T., Hannonen P., Leirisalo-Repo M., Nissilä M., Kautiainen H., Korpela M., Laasonen L., Julkunen H., Luukkainen R., Vuori K. Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trial. FIN-RACo trial group. Lancet. 1999 May 8;353(9164):1568–1573. doi: 10.1016/s0140-6736(98)08513-4. [DOI] [PubMed] [Google Scholar]
  11. Möttönen Timo, Hannonen Pekka, Korpela Markku, Nissilä Martti, Kautiainen Hannu, Ilonen Jorma, Laasonen Leena, Kaipiainen-Seppänen Oili, Franzen Per, Helve Tapani. Delay to institution of therapy and induction of remission using single-drug or combination-disease-modifying antirheumatic drug therapy in early rheumatoid arthritis. Arthritis Rheum. 2002 Apr;46(4):894–898. doi: 10.1002/art.10135. [DOI] [PubMed] [Google Scholar]
  12. Pincus T., Marcum S. B., Callahan L. F. Longterm drug therapy for rheumatoid arthritis in seven rheumatology private practices: II. Second line drugs and prednisone. J Rheumatol. 1992 Dec;19(12):1885–1894. [PubMed] [Google Scholar]
  13. Proudman S. M., Conaghan P. G., Richardson C., Griffiths B., Green M. J., McGonagle D., Wakefield R. J., Reece R. J., Miles S., Adebajo A. Treatment of poor-prognosis early rheumatoid arthritis. A randomized study of treatment with methotrexate, cyclosporin A, and intraarticular corticosteroids compared with sulfasalazine alone. Arthritis Rheum. 2000 Aug;43(8):1809–1819. doi: 10.1002/1529-0131(200008)43:8<1809::AID-ANR17>3.0.CO;2-D. [DOI] [PubMed] [Google Scholar]
  14. Scott D. L., Symmons D. P., Coulton B. L., Popert A. J. Long-term outcome of treating rheumatoid arthritis: results after 20 years. Lancet. 1987 May 16;1(8542):1108–1111. doi: 10.1016/s0140-6736(87)91672-2. [DOI] [PubMed] [Google Scholar]
  15. Sokka Tuulikki, Pincus Theodore. Contemporary disease modifying antirheumatic drugs (DMARD) in patients with recent onset rheumatoid arthritis in a US private practice: methotrexate as the anchor drug in 90% and new DMARD in 30% of patients. J Rheumatol. 2002 Dec;29(12):2521–2524. [PubMed] [Google Scholar]
  16. Weinblatt M. E., Coblyn J. S., Fox D. A., Fraser P. A., Holdsworth D. E., Glass D. N., Trentham D. E. Efficacy of low-dose methotrexate in rheumatoid arthritis. N Engl J Med. 1985 Mar 28;312(13):818–822. doi: 10.1056/NEJM198503283121303. [DOI] [PubMed] [Google Scholar]
  17. Weinblatt M. E., Maier A. L. Longterm experience with low dose weekly methotrexate in rheumatoid arthritis. J Rheumatol Suppl. 1990 May;22:33–38. [PubMed] [Google Scholar]
  18. Weinblatt M. E., Polisson R., Blotner S. D., Sosman J. L., Aliabadi P., Baker N., Weissman B. N. The effects of drug therapy on radiographic progression of rheumatoid arthritis. Results of a 36-week randomized trial comparing methotrexate and auranofin. Arthritis Rheum. 1993 May;36(5):613–619. doi: 10.1002/art.1780360507. [DOI] [PubMed] [Google Scholar]
  19. Weinblatt M. E., Trentham D. E., Fraser P. A., Holdsworth D. E., Falchuk K. R., Weissman B. N., Coblyn J. S. Long-term prospective trial of low-dose methotrexate in rheumatoid arthritis. Arthritis Rheum. 1988 Feb;31(2):167–175. doi: 10.1002/art.1780310203. [DOI] [PubMed] [Google Scholar]
  20. Williams H. J., Willkens R. F., Samuelson C. O., Jr, Alarcón G. S., Guttadauria M., Yarboro C., Polisson R. P., Weiner S. R., Luggen M. E., Billingsley L. M. Comparison of low-dose oral pulse methotrexate and placebo in the treatment of rheumatoid arthritis. A controlled clinical trial. Arthritis Rheum. 1985 Jul;28(7):721–730. doi: 10.1002/art.1780280702. [DOI] [PubMed] [Google Scholar]
  21. van der Heide A., Jacobs J. W., Bijlsma J. W., Heurkens A. H., van Booma-Frankfort C., van der Veen M. J., Haanen H. C., Hofman D. M., van Albada-Kuipers G. A., ter Borg E. J. The effectiveness of early treatment with "second-line" antirheumatic drugs. A randomized, controlled trial. Ann Intern Med. 1996 Apr 15;124(8):699–707. doi: 10.7326/0003-4819-124-8-199604150-00001. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES